Experimental Design & Statistical Framework for Life Sciences
Design statistically rigorous experiments with proper controls and sample sizing
What You Can Do
You can design experiments with appropriate controls, replicate structures, and sample sizes before conducting any bench work. This skill helps you establish clear endpoints, identify confounding variables, select the right statistical tests, and create reproducible data collection protocols—preventing costly failed experiments and increasing publishability.
Features
Convert research questions into measurable primary and secondary endpoints with clear success criteria
Design appropriate positive controls, negative controls, and vehicle controls based on study type and mechanisms
Determine minimum n based on effect size, power (typically 80%), significance level, and variance estimates from literature or pilot data
Match your study design and data type to parametric or non-parametric tests (t-tests, ANOVA, Mann-Whitney U, Kruskal-Wallis, etc.)
Map potential sources of bias (batch effects, circadian rhythms, operator effects, environmental factors) and design mitigation strategies
Build in technical replicates, biological replicates, and randomization protocols for robust results
Ensure design aligns with GLP principles and FDA/EMA expectations for IND/CTA submissions
Debug high variability or failed experiments by analyzing flaws in prior experimental architecture
Example Output
Example 1: Dose-Response Study
Prompt: "Design a dose-response experiment for a new therapeutic candidate. We expect 40% efficacy improvement at the optimal dose, baseline efficacy is 20%, and historical CV is 25%."
Output includes:
- Primary endpoint: % efficacy improvement vs. vehicle control
- Study arms: Vehicle, 3 dose levels (0.1x, 1x, 10x estimated therapeutic dose), positive control
- Sample size: n=12 per group (80% power, α=0.05, two-tailed)
- Statistical test: One-way ANOVA with Dunnett's post-hoc for vehicle comparison
- Controls: Positive control compound, vehicle-matched formulation, environmental controls (temperature, humidity)
- Randomization: Stratified by treatment block, counterbalanced order
Example 2: Mechanism Study with Confounding Variables
Prompt: "We're investigating whether compound X improves cardiac function through AMPK activation. What confounding variables should we control?"
Output includes:
- Primary confounders: Sex, age, baseline metabolic state, fed/fasted status
- Technical confounders: Circadian rhythm effects (measure at same time), operator variability (blinding protocol), equipment drift (daily calibration)
- Recommended design: Sex-stratified analysis, randomized measurement times, blinded operator assessment, environmental chamber for circadian control
- Sample size adjustment: +25% to account for stratification by sex
Example 3: Troubleshooting High Variability
Prompt: "Our PK/PD study showed unexpected high variability (CV >40%). We used n=6 per group. What went wrong in our design?"
Output includes:
- Design flaws identified: Insufficient n (underpowered for detection), no stratification by sex (known PK differences), no fasting standardization, measurement times inconsistent
- Revised design: n=12 per sex, fasted animals only, fixed measurement windows ±15 min
- New power calculation: 80% power to detect 35% efficacy change with revised n and CV estimate
What's Included
- SKILL.md: Full experimental design framework with hypothesis-to-analysis workflow
- Study Design Template: Section-by-section guide covering rationale, endpoints, arms, sample size, controls, randomization, and statistical plan
- Sample Size Calculator Guide: Step-by-step instructions for calculating n using effect size, power, and variance; includes interpretation of common assumptions
- Statistical Test Decision Tree: Flowchart matching study design type, data distribution, and number of groups to appropriate parametric or non-parametric tests
- Confounding Variable Checklist: Comprehensive list of biological, technical, and environmental confounders by experiment type (in vivo, in vitro, PK/PD, mechanistic)
- Regulatory Compliance Checklist: GLP alignment, control requirements, randomization documentation, and FDA/EMA expectations for submissions
Who It's For
- Research Scientists — Designing preclinical or clinical studies with robust statistical foundations
- Biotech R&D Managers — Planning study portfolios and ensuring methodological rigor before resource allocation
- Regulatory Affairs Specialists — Ensuring study designs meet GLP and regulatory expectations for IND/CTA submissions
- Academic Researchers — Building publishable studies with peer-review-ready experimental design and statistical rigor
- Principal Investigators — Managing multiple concurrent studies and troubleshooting high-variability results
Best For
- Designing dose-response, time-course, and efficacy studies before bench work begins
- Planning PK/PD and biomarker investigation studies with multiple arms and endpoints
- Calculating minimum sample sizes based on power, effect size, and variance estimates
- Selecting appropriate statistical tests matched to study design and data type
- Troubleshooting failed or high-variability experiments by auditing experimental architecture
- Responding to peer-review or regulatory feedback questioning study design rigor
You might also like
This skill organizes complex toxicology datasets, clinical adverse events, and mechanistic findings into structured, FDA/EMA-compliant safety narratives. You input raw safety data—adverse event summaries, laboratory results, animal study findings, vital signs—and receive draft safety summaries, detailed safety assessments, and expedited safety reports ready for regulatory submission. It handles IND applications, annual safety updates, clinical development safety overviews, and urgent safety communications with proper MedDRA coding and regulatory formatting.
by kody-w
You can submit tool designs—drawings, specifications, or descriptions—and Claude will evaluate manufacturability constraints, identify potential failure modes using structured frameworks, and recommend cost-reduction opportunities. You'll receive a prioritized report covering structural analysis, production feasibility, material efficiency, and design trade-offs.
by kody-w
You can take unstructured monitoring visit observations and convert them into formal, audit-ready reports that categorize findings by risk level (Critical, Major, Minor), validate protocol compliance, and generate actionable follow-up items with assigned owners and resolution dates. The skill ensures your documentation meets FDA inspection standards and ICH-GCP requirements while creating clear escalation pathways for high-risk issues.
by kody-w
You can automate the validation of clinical trial data against protocol specifications, identify discrepancies including missing values, out-of-range results, protocol violations, and CRF inconsistencies. The skill generates audit-ready query documentation, categorizes anomalies by severity and type, resolves root causes systematically, and produces FDA inspection-ready reports that trace every data decision and corrective action for CDISC and regulatory submission.
by kody-w
You can submit raw mass spectrometry observations, instrument parameters, or sample preparation details to Claude and receive targeted diagnostic frameworks that explain anomalous results. Claude systematically generates plausible mechanistic explanations for unexpected protein abundance patterns, quantification inconsistencies, and PTM findings—then helps you design minimal, hypothesis-driven troubleshooting experiments to test them.
by kody-w
You can validate eCRF and paper CRF datasets against protocol-defined rules, automatically identify data discrepancies (missing fields, out-of-range values, date inconsistencies), generate structured Data Query Forms (DQFs) for site clarification, track resolution status, and create audit-ready compliance documentation that meets FDA 21 CFR Part 11 and GCP requirements. This workflow reduces manual validation time while ensuring 100% traceability and regulatory readiness for inspections.
by kody-w
Get comprehensive PCB design analysis covering power delivery networks, signal integrity, thermal management, and manufacturing constraints. Claude identifies potential issues early and provides specific, actionable optimization recommendations to reduce cost, improve reliability, and accelerate time-to-market. Suitable for designs from initial concept through production-ready layouts.
by kody-w
This skill systematically analyzes your product designs to identify manufacturability issues early, saving costly revisions and manufacturing delays. It evaluates geometry, material selection, tolerances, assembly feasibility, and production process constraints. You get actionable feedback on cost drivers, process risks, and design optimizations before committing to production.
by kody-w